A researcher at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health was awarded a five-year, $544,329 grant from the Centers for Disease Control and Prevention (CDC) to conduct outreach and education on Chagas disease in South Texas.
Fine particulate matter released from a variety of sources in Houston was associated with slight increased mortality risk from 2000 to 2011, according to research from The University of Texas Health Science Center at Houston (UTHealth).
For inventing a completely new way to strike cancer by unlocking a shackled immune system attack, Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center, will receive the nation’s highest honor for clinical medical research.
Cellectis and The University of Texas MD Anderson Cancer Center have entered into a research and development alliance aimed at bringing novel cellular immunotherapies to patients suffering from different types of liquid tumors.
A researcher at The University of Texas MD Anderson Children’s Cancer Hospital will be awarded $250,000 to further his cancer fighting efforts in a special handprint ceremony Sept. 3.
The University of Texas MD Anderson Children’s Cancer Hospital will recognize Childhood Cancer Awareness Month with activities and events geared toward patients and their families, staff and the community. The Be Bold, Go Gold campaign aims to raise awareness of childhood cancers and celebrate survivorship.
The University of Texas MD Anderson Cancer Center has appointed former U.S. Public Health Service four-star Admiral Joxel Garcia, M.D. as the inaugural executive director of the cancer prevention and control platform, part of MD Anderson’s Moon Shots Program. He joins MD Anderson on Aug. 31.
Immatics Biotechnologies GmbH (Immatics) and The University of Texas MD Anderson Cancer Center announced today the launch of Immatics US, Inc., a new company aiming at becoming a global leader in adoptive cellular therapies (ACT) for the treatment of a range of tumor types.
In a first-of-its-kind study, researchers demonstrate a benefit in overall survival among epithelial ovarian cancer (EOC) patients receiving generic heart medications known as beta-blockers. Survival was shown to be greatest among those prescribed first-generation nonselective beta-blockers. According to The University of Texas MD Anderson Cancer Center investigators, the drugs block the effects of stress pathways involved in tumor growth and spread.
Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
Merck and The University of Texas MD Anderson Cancer Center announced a strategic clinical research collaboration to evaluate Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in combination with other treatments, such as chemotherapy, radiation therapy and/or novel anti-tumor medicines.
Five globe-trotting, sun-blocking superheroes teach preschoolers about lifelong sun safety in a new curriculum available this summer based on research at The University of Texas MD Anderson Cancer Center.
Internationally respected surgeon, Valerae O. Lewis, M.D., has been named chair of Orthopaedic Oncology at The University of Texas MD Anderson Cancer Center.
Harris Health System has named Dr. Parikshet A. Babber its new executive vice president and chief medical officer to oversee quality, utilization management and medical staff services for the safety-net healthcare system.
A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
Women who receive a shorter course of whole breast radiation therapy for early stage disease experience less toxicity and improved quality of life compared to those who undergo a longer course of treatment, researchers report from The University of Texas MD Anderson Cancer Center.
Study shows that cell plasticity program resulting from kidney damage can be targeted to reverse disease and fibrosis.
DNA double-strand breaks (DSBs) are the worst possible form of genetic malfunction that can cause cancer and resistance to therapy.
Hailed as the Bill of Rights for individuals with disabilities, the Americans with Disabilities Act (ADA) of 1990 has fulfilled much of its promise since it went into effect 25 years ago, according to a survey of disability leaders, released on July 23 in Washington, D.C. But the findings also reveal ongoing and emerging challenges and areas of opportunity.
Kayo Fujimoto, Ph.D., assistant professor in the Center for Health Promotion and Prevention Research at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, has been awarded a grant to study the genetic and social network aspects of human immunodeficiency virus (HIV) transmission.
Ben Taub Hospital, best known for its expert trauma care, is quickly building a national reputation for cardiovascular services. The Harris Health System hospital was recently designated Chest Pain Center with Primary PCI (the minimal surgical procedure to unclog blocked heart vessels) by the Society of Cardiovascular Patient Care. Additionally, the hospital earned the Platinum Performance Achievement Award ACTION Registry®—GWTG™ from the National Cardiovascular Data Registry—a distinction only awarded 319 hospitals in the U.S.
The first test ever constructed to assess Persistent Complex Bereavement Disorder—a problematic syndrome of grief—has been jointly published by researchers from The University of Texas Health Science Center at Houston (UTHealth) and The University of California, Los Angeles (UCLA).
The University of Texas MD Anderson Cancer Center has been named a site for one of two new Genome Characterization Centers (GCC) funded through the National Cancer Institute (NCI).
The Houston Methodist Neurological Institute's new Center for Neuroregenerative Medicine scientific director is Philip Horner, Ph.D., an expert on the use of stem cells to replace damaged brain and spinal cord tissue.
The University of Texas MD Anderson Cancer Center has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report’s “Best Hospitals” survey.
Hereditary colorectal cancers, caused by inherited gene mutations, are relatively rare for most patients.
Every parent knows the maxim “feed a cold, starve a fever.” In cancer, however, exactly how to feed or starve a tumor has not been easy to determine.
Free cervical and breast cancer screenings and community health information will be available for women ages 21 to 64 who are uninsured or underinsured at the “See, Test & Treat” event hosted by UT Physicians Bayshore Multispecialty Clinic on Saturday, Aug. 1.
Allison Edwards, Dr.P.H., R.N., assistant professor at The University of Texas Health Science Center at Houston (UTHealth) School of Nursing, was appointed to the Texas Board of Nursing by Gov. Greg Abbott.
From 2004 to 2010 in Texas, mental illness was the most common reason for the hospitalization of children ages 10-14 while pregnancy/birth was the most common reason for the hospitalization of adolescents ages 15-17, according to researchers at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
For the fifth year in a row, Harris Health System earned the “Most Wired” recognition in the 17th annual survey and benchmarking study conducted by the American Hospital Association’s Health Forum and the College of Healthcare Information Management Executives. This year, Harris Health joins two other healthcare systems in greater Houston and 15 others in Texas to be recognized as Most Wired.
Charles Darkoh, Ph.D., a researcher at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health, was recently awarded a five-year, $1.9 million R01 grant by the National Institutes of Health (NIH) to develop a non-antibiotic treatment for Clostridium difficile (C-diff) infections.
Sylvia Hernando became a Community Health Worker (CHW) because she wanted to help others. Hernando had been a stay-at-home mother and was looking to go back to school when she heard about the CHW certification program at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Light switches for neurons have made enormous contributions to brain research by giving investigators access to “on switches” for brain cells. But, finding “off switches” has been much more challenging. Addressing the challenge, biochemists in the Center for Membrane Biology at The University of Texas Health Science Center at Houston (UTHealth) discovered a new family of light-activated proteins that work as “off switches.”
Dr. Ericka Brown has been named executive vice president and administrator of Harris Health System’s Ben Taub Hospital, a 586-licensed-bed facility and one of the nation’s premiere Level 1 trauma centers. The hospital also has earned the Comprehensive Stroke Center Certification by DNV Healthcare, the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus-Target: Stroke Honor Roll Elite Plus Award and the 2015 Mission: Lifeline® Gold Plus Receiving Center award from the American Heart Association for its treatment of severe heart attack patients—STEMI (ST-elevation myocardial infarction).
It may seem incredulous, but breast tumors may have something in common with embryos … at least in mice, say researchers at The University of Texas MD Anderson Cancer Center.
As the Fourth of July quickly approaches, people are preparing delicious side dishes to take to backyard cookouts. Unfortunately, these high-calorie side dishes can create a challenge for people who want to maintain or lose weight while still enjoying summer festivities.
A protein encoded by the gene glypican-1 (GPC1) present on cancer exosomes may be used as part of a potential non-invasive diagnostic and screening tool to detect early pancreatic cancer, potentially at a stage amenable to surgical treatment, according to a study at The University of Texas MD Anderson Cancer Center.
The costs associated with cancer drug prices have risen dramatically over the past fifteen years, which is of concern to many top oncologists. In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
Harris Health System and researchers from Baylor College of Medicine are enrolling Type 2 diabetes patients who have been diagnosed within the last 10 years and are only taking metformin, the most common first-line diabetes medication prescribed, to participate in one of the nation’s largest and most comprehensive studies ever conducted by the National Institutes of Health. The major goal of the study is to identify how patients on metformin respond when their medication is coupled with one of four other diabetes drugs. Results from the study could have a significant impact on diabetes treatment for years to come.
Cutaneous melanoma, the most deadly form of skin cancer, is now believed to be divided into four distinct genomic subtypes, say researchers at The University of Texas MD Anderson Cancer Center, a finding that could prove valuable in the ever-increasing pursuit of personalized medicine.
The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT.
Although traditionally understood to induce death in cancer cells, researchers at The University of Texas MD Anderson Cancer Center have discovered that the DAPK1 protein is actually essential for growth in breast and other cancers with mutations in the TP53 gene. This discovery indicates DAPK1 may be a promising new therapeutic target for many of the most aggressive cancers.
There is the Addams Family. And then there is the ADAMTS family. While one is mindless entertainment, the latter may prove to be a new genetic avenue for designing ovarian cancer treatment.
Mutations in ARID1a, which are common in many cancer types, disrupt DNA damage repair in cancer cells, allowing the cancer to progress.
Not all brain cancers are the same but together they represent a deadly disease that has been difficult to identify and treat.
Adults who use proton pump inhibitors are between 16 and 21 percent more likely to experience a heart attack than people who don't use the commonly prescribed antacid drugs, according to a massive new study by Houston Methodist and Stanford University scientists.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right